Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Myeloma
Closed
Phase 3
This trial is looking at adding isatuximab to lenalidomide and dexamethasone for myeloma. It is for people who have myeloma without symptoms. This is called smouldering myeloma.
The trial is for people with smouldering myeloma who have a high chance of developing symptoms.
Recruitment start: 4 June 2021
Recruitment end: 1 January 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Mamta Garg
Sanofi
Last reviewed: 08 Mar 2023
CRUK internal database number: 18462
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
